Wordt geladen...
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
Existing recombinant adeno-associated virus (rAAV) serotypes for delivering in vivo gene therapy treatments for human liver diseases have not yielded combined high-level human hepatocyte transduction and favorable humoral neutralization properties in diverse patient groups. Yet, these combined prope...
Bewaard in:
Gepubliceerd in: | Mol Ther |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Gene & Cell Therapy
2018
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5763027/ https://ncbi.nlm.nih.gov/pubmed/29055620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.09.021 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|